Janus Divalent Nucleobases for RNA Secondary Structure Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for targeting and manipulating RNA sequences are limited by their stability and specificity, particularly in binding to mismatched or secondary structures, which are crucial for gene regulation and therapeutic applications.

Innovation Solution

Development of 'Janus' nucleobases that can form directional hydrogen bonding interactions with both strands of DNA or RNA double helices, integrated into a γPNA backbone for enhanced binding capabilities and sequence specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional nucleobases are used for binding to DNA or RNA, then binding to canonical base-pairs is achieved, but binding to mismatched or secondary structures is insufficient

Engineering Contradiction:
Improvebinding specificityVSAvoidbinding to mismatched structures
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The nucleobase is divided into two independent binding faces, each capable of forming hydrogen bonds with complementary bases on opposite strands. This segmentation allows the single nucleobase to simultaneously recognize and bind to both strands, including mismatched configurations, thereby resolving the contradiction between specific binding and adaptability to various structures.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The divalent nucleobase is designed to perform multiple binding functions: it can bind to canonical Watson-Crick base-pairs, mismatched base-pairs, and various secondary structures (hairpins, bulges, junctions) in RNA. This multi-functionality enables a single molecular tool to address diverse binding scenarios, improving both reliability and versatility simultaneously.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If molecules are designed to bind sequence-specifically to control genetic information flow, then therapeutic and diagnostic applications are enabled, but the complexity of designing and synthesizing such molecules increases

Engineering Contradiction:
Improvesequence-specific binding capabilityVSAvoidmolecule design and synthesis complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention changes the fundamental parameter of nucleobase valency from monovalent to divalent, creating a new class of nucleobases that bind to two strands simultaneously. This parameter change simplifies the design process compared to traditional multi-component systems, as the divalent nucleobase inherently provides sequence-specific binding through its dual hydrogen-bonding capability, reducing the need for complex assembly steps.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If RNA secondary structures are targeted for therapeutic intervention, then gene regulation is achieved, but the stability and accessibility of RNA structures for binding is reduced

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidRNA structure stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The divalent nucleobase acts as an intermediary that can penetrate and bind to stable RNA secondary structures. By forming hydrogen bonds with bases in hairpins, bulges, and junctions, the divalent nucleobase serves as a mediator that stabilizes the binding interaction and enables therapeutic intervention in otherwise stable and inaccessible RNA structures.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables selective binding to double-stranded nucleic acid sequences, including mismatched and secondary structures, improving gene regulation and providing therapeutic and diagnostic tools for genetic diseases and infections.

Implementation Method 1

Janus nucleobases are capable of forming directional hydrogen bonding interactions with both strands of the DNA and/or RNA double helix

Methodology Applied
Scientific EffectHydrogen bonding:

Data Source

PatentUS11713340B2Divalent nucleobase compounds and uses therefor
Publication Date: 2023.08.01 CARNEGIE MELLON UNIV
  • US11713340B2 patent drawing
  • US11713340B2 patent drawing
  • US11713340B2 patent drawing

AI summary

Described herein are novel divalent nucleobases that each bind two nucleic acid strands, matched or mismatched when incorporated into a nucleic acid or nucleic acid analog backbone (a genetic recognition reagent, or genetic recognition reagent). In one embodiment, the genetic recognition reagent is a peptide nucleic acid (PNA) or gamma PNA (γPNA) oligomer. Uses of the divalent nucleobases and monomers and genetic recognition reagents containing the divalent nucleobases also are provided.